Licensing Agreement Guide: Royalties, Exclusivity, IP Ownership & Negotiation Strategies

A licensing agreement is a contract in which the owner of intellectual property (the licensor) grants another party (the licensee) the right to use that IP under defined conditions — without transferring ownership. Licensing is the primary mechanism through which IP rights are commercially exploited: software is licensed, not sold; films are licensed to distributors; patents are licensed to manufacturers; trademarks are licensed to franchisees and brand partners. The global IP licensing market generates over $300 billion in annual royalty revenues, and the terms of individual license agreements determine how that value is allocated.

Types of IP that can be licensed: Patents (rights to make, use, sell, import under 35 U.S.C. § 271), trademarks (brand use under the Lanham Act), copyrights (reproduction, display, distribution, derivative works under 17 U.S.C. § 106), trade secrets (confidential formulas or processes under the DTSA), and software (licensed under both copyright and, often, patent protection). Each IP type carries different legal requirements for the license agreement, different enforcement mechanisms, and different risk profiles.

The Grant Clause — the most important sentence in any license. The grant clause creates the licensee's rights and defines their entire scope. It must specify: (1) the type of license (exclusive, non-exclusive, sole); (2) the specific IP licensed (by registration number or detailed description — vague IP descriptions invite litigation); (3) the licensed acts (make, use, sell, offer for sale, import — each right is separately significant, especially for patents); (4) the field of use; and (5) the territory. Any right not expressly granted is reserved to the licensor. In Speedplay, Inc. v. Bebop, Inc., 211 F.3d 1245 (9th Cir. 2000), the court held that a license purporting to grant “all rights” still did not constitute an assignment in the absence of a formal written transfer — leaving the licensee without independent patent enforcement standing.

Related guides: Intellectual Property in Contracts Guide and Confidentiality Clause Guide.

The type of license granted is the single most economically significant term in a licensing agreement. It determines whether the licensee is the only market participant with rights to the IP, whether the licensor can compete with the licensee, and what the license is worth both commercially and legally.

Field-of-Use Restrictions. A field-of-use limitation confines the license to a specific market segment — for example, a polymer patent licensed to one company for medical devices and another for automotive applications. The Supreme Court upheld field-of-use restrictions in General Talking Pictures Corp. v. Western Electric Co., 304 U.S. 175 (1938), and the principle remains good law. Licensees should define their field broadly enough to cover current and anticipated future products, while recognizing that licensors will push for narrow definitions to preserve optionality.

Cross-Licensing. In technology-heavy industries (semiconductors, telecommunications, mobile, automotive), companies hold large patent portfolios and license to each other reciprocally — often at zero royalties or reduced rates — to reduce litigation risk between peers. Key cross-license issues: which patents are covered, which products, how future patents acquired after the agreement is signed are treated, and whether a change of control (acquisition of one party) terminates or survives the cross-license.

Royalties are the economic engine of any licensing agreement. Understanding the five primary royalty models — and the Net Sales definition that determines the royalty base — is essential before signing any license that includes a financial obligation.

Five Primary Royalty Models

Net Sales Definition — The Devil in the Details. The Net Sales definition determines the royalty base and is frequently a major negotiation battleground. Licensors prefer broad definitions; licensees prefer narrow definitions that deduct discounts, returns, freight, taxes, insurance, and other cost items. Common disputes: (1) how “bundled” products sold as a package are allocated; (2) whether affiliated-party sales are valued at list price or transfer price; (3) how foreign currency is converted; and (4) whether sublicensing revenue received from sub-licensees is subject to the full royalty rate or a reduced rate (typically 20–50%). The difference between a broad and narrow Net Sales definition can shift effective royalty rates by 15–25% even at the same stated percentage.

Audit Rights. Running royalties require robust audit provisions because the licensor depends on the licensee's self-reporting for payment accuracy. Standard provisions: right to inspect the licensee's books annually upon 30–60 days notice, at the licensor's expense unless the audit reveals an underpayment exceeding 5–10% (in which case the licensee bears audit costs). A most-favored-licensee (MFL) clause guarantees that if the licensor later grants a lower royalty rate to another licensee for the same rights, the current licensee's rate is automatically reduced to match — protecting early licensees from being commercially disadvantaged by later, better-negotiated deals.

IP ownership provisions determine who owns the value created during the license relationship — and whether the licensee's own innovations may be captured by the licensor. Improvement clauses in technology and pharmaceutical licenses are among the most heavily negotiated provisions and can determine whether a licensee's multi-year R&D program ultimately benefits the licensor's portfolio instead of the licensee's competitive position.

Grant-Back Clauses — Major Risk for Licensees. A grant-back provision requires the licensee to assign or license to the licensor any improvements the licensee makes to the licensed IP. Assignment-based grant-backs are among the most dangerous provisions for licensees investing in R&D: the licensee's own innovations become the licensor's property, which the licensor can then license to the licensee's competitors. In Kimble v. Marvel Entertainment, 576 U.S. 446 (2015), the Supreme Court confirmed that royalty obligations tied to improvement grant-backs may persist even after patent expiration, creating a long-term royalty trap that has no natural termination date.

Jointly Developed IP. When both parties contribute to developing new IP under the license relationship, joint ownership creates significant legal complications. Under 35 U.S.C. § 262, each co-owner of a U.S. patent may independently exploit the patent and grant non-exclusive licenses without the other co-owner's consent. This means your joint-IP partner can license the jointly held patent to your direct competitor without your permission and without sharing the royalty income — a commercially devastating outcome. Always contract around § 262 by restricting each joint owner's sublicensing rights or by vesting ownership in one party with a license-back to the other.

Trademark licensing carries a unique obligation that has no parallel in patent or copyright licensing: the licensor must maintain actual quality control over the licensee's use of the mark. Failure to do so creates a “naked license” — which can result in the licensor losing its trademark rights entirely. This is not a theoretical risk; courts have cancelled trademark registrations and stripped brand owners of their marks for failure to exercise adequate control.

In Barcamerica Int'l USA Trust v. Tyfield Importers, Inc., 289 F.3d 589 (9th Cir. 2002), the Ninth Circuit held that a trademark licensor who failed to exercise meaningful quality control over a licensee's wine products had created a naked license, causing the mark to be deemed abandoned. The court emphasized that quality control must be actual and meaningful — a contractual right of inspection that is never exercised does not satisfy the standard. The licensor's trademark was cancelled.

Quality control for patent and copyright licenses is less legally mandated but commercially important. Patent licensors who care about the reputation of their technology should include minimum performance standards, use restrictions, and the right to audit for compliance. Copyright licensors licensing creative works (music, film, software, design) should specify: permitted uses, prohibited modifications, attribution requirements, and approval rights over derivative works that will be distributed publicly.

The term of a license agreement determines how long the licensee has rights to use the IP. Most commercial licenses are for fixed initial terms (3–10 years is common in technology licensing) with renewal options. Perpetual licenses — which run for the life of the underlying IP — are available but command higher upfront or ongoing royalties. The termination provisions determine the circumstances under which the license can be ended early and with what consequences.

Termination Rights to Negotiate (as a Licensee):

Licensor Bankruptcy — 11 U.S.C. § 365(n). If the licensor files for bankruptcy, the trustee may attempt to “reject” (terminate) the license agreement as an executory contract under 11 U.S.C. § 365(a). Section 365(n) provides specific licensee protections: if the trustee rejects the agreement, the licensee may elect to retain its rights to the licensed IP for the duration of the agreement — including renewal rights — in exchange for continuing to pay royalties. However, the licensor (trustee) is no longer obligated to provide affirmative support (development, updates, maintenance) — only the passive right to use the IP remains.

For trademark licenses specifically, the Supreme Court in Mission Product Holdings, Inc. v. Tempnology, LLC, 587 U.S. 370 (2019), held that rejection of a trademark license in bankruptcy does not strip the licensee of the right to continue using the mark — rejection has the same consequences as a breach of contract, not a rescission. Always include an express § 365(n) election clause and negotiate for a technology escrow (source code deposited with a third party accessible to the licensee if the licensor becomes insolvent) for software licenses.

Related guides: Franchise Agreement Guide · Software Development Agreement Guide · Intellectual Property in Contracts Guide.

Licensing law varies significantly by state — governing everything from trade secret protection, to trademark abandonment standards, to how royalty disputes are resolved in court. The governing law clause in your license determines which state's rules apply to interpretation and enforcement.

Table reflects general commercial licensing law as of March 2026. State statutes and case law evolve — verify current law before relying on these entries.

Use this matrix when reviewing a licensing agreement. Match the clause or structure you see to the scenario, assess risk, and apply the counter-offer strategy.

In a licensing agreement, IP indemnification typically runs from licensor to licensee — the reverse of the typical vendor indemnification in a services contract. The licensor grants the licensee rights to use IP; if a third party claims that the licensed IP infringes their intellectual property rights, the licensor should be the one to defend and indemnify. This allocation makes economic sense: the licensor is in the best position to know whether the IP is clear for commercial use and to defend its validity and ownership.

What licensor IP indemnification should cover: defense costs (attorney fees, expert fees), damages awarded in any infringement judgment, and settlement amounts — for claims arising from the licensee's use of the licensed IP within the licensed scope, field of use, and territory. The licensor's obligation should also include the right and obligation to control the defense of any covered claim — allowing the licensor to use its own patent counsel who knows the IP.

Related guides: Limitation of Liability Guide and Indemnification Clause Guide.